Vincent van der Wel

Vincent van der Wel holds degrees in Medicine, Business Studies and Health Economics, a combination that gives him a unique perspective bridging the clinical, economic and regulatory dimensions of medicines development.

As founder of Orfenix, Vincent has helped establish and fund five public–private partnerships developing treatments for rare diseases, while supporting more than 15 academic medicines development projects. He is actively involved in platforms such as Medicine for Society and Rare-NL, the national hub for drug repurposing and rare diseases.

Vincent contributes to scientific research on orphan medicine development and pricing, and mentors PhD students at Amsterdam UMC. He holds certificates in regulatory affairs and clinical development, with hands-on experience of national and European regulatory interactions, including orphan designations and scientific advice procedures.